# Efficacy of Coreg CR and Lisinopril on Markers for Cardiovascular Functional and Structural Disease

> **NCT00553969** · PHASE1,PHASE2 · COMPLETED · sponsor: **University of Minnesota** · enrollment: 101 (actual)

## Conditions studied

- Pre-hypertension

## Interventions

- **DRUG:** carvedilol phosphate
- **DRUG:** lisinopril
- **DRUG:** carvedilol phosphate and lisinopril
- **DRUG:** placebo and placebo

## Key facts

- **NCT ID:** NCT00553969
- **Lead sponsor:** University of Minnesota
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-11
- **Primary completion:** 2010-09
- **Final completion:** 2010-12
- **Target enrollment:** 101 (ACTUAL)
- **Last updated:** 2018-04-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00553969

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00553969, "Efficacy of Coreg CR and Lisinopril on Markers for Cardiovascular Functional and Structural Disease". Retrieved via AI Analytics 2026-07-25 from https://api.ai-analytics.org/clinical/NCT00553969. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*